Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
Recruiting - Colorado Blood Cancer Institute
Denver, Colorado, United States
Recruiting - Columbia University
New York, New York, United States
Recruiting - Oregon Health and Science University
Portland, Oregon, United States
Recruiting - Vanderbilt University
Nashville, Tennessee, United States
Recruiting - University of Texas Southwestern
Dallas, Texas, United States
Recruiting - University of Utah
Salt Lake City, Utah, United States
Recruiting - University of Washington
Seattle, Washington, United States
Recruiting - University of Wisconsin - Carbone
Madison, Wisconsin, United States
Recruiting - Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Dec 2023
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2029
- Last update posted
- 2 Jun 2026
- Registered enrollment
- 300
- Registry id
- NCT05231629
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.